Myriad Genetics reported $15.4M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Agilent A:US $ 1010M 73M
Becton, Dickinson and BDX:US $ 3163M 95M
Bio Rad Laboratories BIO:US $ 657.13M 51.64M
Bruker BRKR:US $ 759M 19.1M
Danaher DHR:US $ 3257M 185M
Exact Sciences EXAS:US $ 115.17M 2.21M
Illumina ILMN:US $ 518M 53M
Mettler Toledo International MTD:US 463.32M 16.83M
Myriad Genetics MYGN:US $ 15.4M 0.2M
Nanostring Technologies NSTG:US $ 41.52M 6.93M
Orasure Technologies OSUR:US $ 71.3M 9.77M
Pacific Biosciences Of California PACB:US $ 36.12M 6.5M
Perkinelmer PKI:US $ 624.3M 21.63M
Quest Diagnostics DGX:US $ 187M 10M
Quidel QDEL:US $ 552.7M 371.31M
Repligen RGEN:US $ 239.12M 25.34M
Thermo Fisher Scientific TMO:US $ 5668M 185M
Veracyte VCYT:US $ 14.6M 2.23M
Waters WAT:US $ 409.92M 28.02M